BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,512,784 | -1.3% | 229,247 | +24.3% | 0.41% | +14.2% |
| Q2 2023 | $11,660,590 | +11.6% | 184,503 | -20.5% | 0.36% | +12.9% |
| Q1 2023 | $10,447,533 | +6.1% | 232,219 | +3.3% | 0.32% | +5.6% |
| Q4 2022 | $9,849,101 | +3.7% | 224,814 | +55.9% | 0.30% | -2.9% |
| Q3 2022 | $9,500,000 | +81.5% | 144,177 | +39.1% | 0.31% | +73.2% |
| Q2 2022 | $5,235,000 | -47.7% | 103,646 | -33.8% | 0.18% | -27.8% |
| Q1 2022 | $10,007,000 | +84.2% | 156,646 | +208.8% | 0.25% | +121.4% |
| Q4 2021 | $5,433,000 | +0.1% | 50,725 | -3.9% | 0.11% | +8.7% |
| Q3 2021 | $5,428,000 | -0.9% | 52,797 | -15.2% | 0.10% | +1.0% |
| Q2 2021 | $5,478,000 | -4.4% | 62,278 | +5.7% | 0.10% | -15.7% |
| Q1 2021 | $5,728,000 | -47.8% | 58,907 | -39.8% | 0.12% | -50.8% |
| Q4 2020 | $10,966,000 | -8.0% | 97,782 | -23.9% | 0.25% | -39.1% |
| Q3 2020 | $11,917,000 | +38.0% | 128,559 | +16.1% | 0.40% | +29.5% |
| Q2 2020 | $8,637,000 | – | 110,726 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 521,673 | $53,633,000 | 9.74% |
| Eagle Health Investments LP | 176,175 | $18,113,000 | 5.74% |
| DAFNA Capital Management LLC | 206,911 | $21,273,000 | 5.64% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,052,203 | $108,177,000 | 4.08% |
| Casdin Capital, LLC | 1,550,000 | $159,356,000 | 3.97% |
| SIB LLC | 65,151 | $6,698,000 | 3.70% |
| Integral Health Asset Management, LLC | 98,000 | $10,075,000 | 2.90% |
| Avidity Partners Management LP | 832,000 | $85,538,000 | 1.90% |
| Rock Springs Capital Management LP | 849,659 | $87,353,000 | 1.84% |
| Boxer Capital, LLC | 425,000 | $43,694,000 | 1.53% |